Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > And management is not interested in .64 cent shares?
View:
Post by Stutters on Jun 16, 2022 10:04am

And management is not interested in .64 cent shares?

hmmmm. Thats funny. :)
Comment by Duster340 on Jun 16, 2022 10:44am
ana stegic bought 28,500 last month @70 cents, however i too would like to see insiders stepping up, giving shareholders some confidence, and maybe getting the stock back to atleast the 70 cent range.
Comment by MrMugsy on Jun 16, 2022 12:03pm
I would bet we'll see some buying from the top team/board (or certain individuals) once they aren't sitting on material information.  I would also think Ana is far removed from material information. That's how I would read it.
Comment by StockingUp21 on Jun 16, 2022 4:13pm
I read this as you know they have materialinfo that stops insider buying but this lady that must report as insider doesnt know they have material info so is able to buy
Comment by MrMugsy on Jun 16, 2022 7:42pm
Right - that's what I'm saying - but - it's simply a thought. Ana is involved in clinical operations and she's preparing for Phase 2 - maybe on the enrollment side and preparing for the process with outside labs.  She might be following instructions laid out for her in that respect and she doesn't need to be involved in other matters that may be material at this time ...more  
Comment by MrMugsy on Jun 16, 2022 7:47pm
Also - understand that I'm only making assumptions about what Ana does at ATE - considering her role is in "Clinical Operations."  
Comment by Inthepez on Jun 16, 2022 7:57pm
looks like the dumpster took his lithium today. He was had a manic episode for a few comments a day ago.  All he does is tell you the prices and sky are falling. Never does he make predictions. Only staying either the obvious or bashes a like a typical asshat. ADDS ZERO VALUE TO THE BOARD. A few select ones on other boards that sounds like deja vu:  Hive: big red day bitcoin ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities